Vidarbha News

Next Generation Sequencing Market Anticipated to Achieve Profitable Growth Of $19.70 Billion By 2025: Grand View Research, Inc

 Breaking News
  • No posts were found

Next Generation Sequencing Market Anticipated to Achieve Profitable Growth Of $19.70 Billion By 2025: Grand View Research, Inc

November 20
08:31 2019
Next Generation Sequencing Market Anticipated to Achieve Profitable Growth Of $19.70 Billion By 2025: Grand View Research, Inc

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, The global Next Generation Sequencing market size was valued at USD 8.49 billion in 2018 and is expected to register a CAGR of 12.78% over the forecast period.

The global next generation sequencing market is expected to reach USD 19.70 billion by 2025 registering a CAGR of 12.78%, according to a new report by Grand View Research, Inc. Growing application of NGS methodologies due to rising number of strategic developments initiated by the market participants is one of the key drivers of the market. These novel strategies mark the presence of intense competition between the key firms. Companies are further increasing their installation base by providing sequencing services in different emerging countries. For instance, in April 2018, Illumina entered into a partnership with Loxo Oncology for the development of Illumina TruSight Tumor 170 NGS test as a companion diagnostic for Loxo Oncology’s LOXO-292 and larotrectinib for tumor profiling.

Similarly, in March 2018, PierianDx partnered with cancer genetics to offer NGS-based tests for oncology precision medicine. NGS technologies experience significant growth due to rapid automation in the pre-sequencing protocols and advancements in clinical diagnosis and disease testing. Wide application of this technique in oncology, reproductive screening, infectious disease, noninvasive prenatal testing, and pharmacogenomics is also expected to positively impact the market growth. Reduced costs of genetic sequencing has also significantly enhanced the adoption of these technologies. Reduced installation costs of NGS platforms and easy availability of proteomic and genomic data has also resulted in an increased demand, thereby propelling the market development.

Browse Details of Report, Please Visit @

U.K. next generation sequencing market size, by technology, 2014 - 2025 (USD Million)

Key Takeaways from the report:

  • NGS-based platforms & related products account for the dominant market share due to the presence of sequencing platforms and instruments required for clinical applications
  • Growing awareness related to NGS services is likely to boost growth of the services segment
  • Cancer-related genes have a high level of genomic heterogeneity that can be easily detected by NGS, thus resulting in maximum revenue flow from the oncology field
  • On the basis of workflow, sequencing vertical accounted for the largest revenue share of the NGS market in 2018 and is said to continue its dominance over the forecast period
  • High demand for this technology and usage of NGS platforms for several research projects and Ph.D. programs contributes to academic research segment’s growth
  • Whereas, clinical research segment will witness a significant CAGR owing to emergence of NGS applications in clinical research and studies
  • North American held the maximum revenue share in 2018 due to the presence of a number of NGS technology providers, such as Illumina and Thermo Fisher
  • Asia Pacific is expected to emerge as the fastest-growing region due to continuous improvements laid by key participants in emerging economies, such as China and India
  • Prominent companies in the global market include Illumina Inc.; QIAGEN; F Hoffman-La Roche Ltd.; Thermo Fisher Scientific Inc.; and Bio-Rad Laboratories, Inc.
  • Product development and M&A are some of the key strategies adopted by these companies, for instance, Illumina acquired Edico Genome to improve the overall efficiency of NGS solutions provided by Illumina

Global next generation sequencing market share, by end use, 2018 (%)

Request For Free Sample Report @  

Table of Contents

Chapter 1 Research Methodology & Scope
                   1.1 Information Procurement
                       1.1.1 Purchased database:
                       1.1.2 GVR’s internal database
                       1.1.3 Secondary sources:
                       1.1.4 Third Party Perspective:
                       1.1.5 Primary Research:
                   1.2 Information or Data Analysis
                   1.3 Market Formulation & Validation
                   1.4 Region Wise Market Calculation
                       1.4.1 Region wise market: Base estimates
                       1.4.2 Global market: CAGR calculation
                       1.4.3 Region based segment share calculation
Chapter 2 Executive Summary
                   2.1 Next Generation Sequencing Market Outlook, 2014 – 2025
                   2.2 Next Generation Sequencing Market : Segment Outlook, 2014 – 2025
                   2.3 Next Generation Sequencing Market : Competitive Insights
Chapter 3 Next Generation Sequencing Market Variables, Trends, & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market outlook
                       3.1.2 Related/ancillary market outlook
                   3.2 Penetration & Growth Prospect Mapping for Applications, 2018
                   3.3 Penetration & Growth Prospect Mapping for Prominent Industry Players, 2018
                   3.4 Product Pipeline Analysis, by Stage
                   3.5 Cost Structure Analysis
                   3.6 User Perspective Analysis
                       3.6.1 Consumer behavior analysis
                       3.6.2 Market influencer analysis
                   3.7 Procedure Cost Analysis
                   3.8 End-use analysis
                   3.9 Technology Overview
                       3.9.1 Technology timeline
                   3.10 Regulatory Framework
                       3.10.1 Next generation sequencing reimbursement scenario
                  Gap fill approach for reimbursement of NGS tests
                  Role of the commercial payers
                      Payer perspectives for developing coverage policy for Next Generation Tumor Sequencing Panels (NGTS)

Browse Related Reports :

Clinical Oncology Next Generation Sequencing Market
Size, Share & Trends Analysis Report By Technology, By Workflow, By Application, By End Use, By Region, And Segment Forecasts, 2019 – 2025

U.S. Clinical Oncology Next Generation Sequencing (NGS) Market Size & Forecast By Technology (Whole Genome Sequencing, Whole Exon Sequencing, Targeted Sequencing & Resequencing), By Workflow (NGS Pre-Sequencing, Sequencing, NGS Data Analysis, Primary, Secondary & Tertiary Data Analysis), By End Use (Academic & Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities) And Trend Analysis From 2018 To 2024

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States